Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
about
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophagesActivities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse modelA bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditionsRifabutin is active in murine models of toxoplasmosisFormulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infectionA Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice.Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice.Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.Use of PCR in detection of Mycobacterium avium complex (MAC) bacteremia: sensitivity of the assay and effect of treatment for MAC infection on concentrations of human immunodeficiency virus in plasmaSpecies identification of Mycobacterium avium complex isolates by a variety of molecular techniques.PCR-hybridization assay for Mycobacterium avium complex: optimization of detection in peripheral blood from humansA genetic mechanism for deletion of the ser2 gene cluster and formation of rough morphological variants of Mycobacterium avium.Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorPharmacokinetics of clarithromycin and zidovudine in patients with AIDS.Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection.Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in miceEvaluation of Aro-Tal-AST Complex Protein as a Marker for Differential Diagnosis of Mycobacterium Avium Infection.Surviving the acid test: responses of gram-positive bacteria to low pH.Epidemiology of infection by nontuberculous mycobacteriaImmunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8.Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complexIntracellular fate of Mycobacterium avium: use of dual-label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interactionEpidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infectionMycobacterium avium complex and Mycobacterium tuberculosis in patients infected with the human immunodeficiency virusThe phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.Search for the molecular basis of morphological variation in Mycobacterium avium.Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complexEfficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium aviumPharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse modelUse of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patients.Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient.Genetic diversity among Mycobacterium avium complex AccuProbe-positive isolatesRapid detection of Mycobacterium avium in stool samples from AIDS patients by immunomagnetic PCR.Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes.Detection and identification of mycobacteria by amplification of RNA and DNA in pretreated blood and bone marrow aspirates by a simple lysis methodCaring for patients with HIV infection. Management plan for family physicians.Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor.Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare
P2860
Q28326992-D97BF057-C9C8-47A6-AEC8-A4E8FD3D6431Q28368218-E888FA9D-5362-47E0-A3A2-477068DF558AQ28368663-14748922-E03A-436D-A6AE-B198DA9675DBQ28378281-B74338E9-020B-4D6B-BDE7-54AB02658BA2Q28378749-B5A0F26B-4374-4706-B751-2C594FA8021CQ33212752-8CE9A398-249A-41DE-A3B6-C6869E6BE5D9Q33603597-E550FA0C-5EF0-48AB-90AF-20C94B2A0EC4Q33745057-3B97F509-546C-4DE0-B632-BDE0776638C7Q33958051-158B59A9-CE48-4599-9EEA-9F66F7ECFAA9Q33965261-893203FB-E83A-43F7-AB20-3B268C1B62A5Q33972068-328947DC-0769-4CE8-917A-AB0AB54B901BQ33994827-53D84E89-C755-430C-AF41-347138506948Q34522402-FEC83DF0-C1A9-4EFE-B232-A32AD5EB7475Q35115453-F9C2ECB6-F545-4FFA-905B-AC257560416BQ35125757-F9354AF9-2B7C-451E-8C97-9454CB6A2536Q35130708-23150A0C-980C-4C1E-9F4A-581F621F2AC5Q35132348-42D36C50-0CF2-49DC-965A-4F7327B1EEA6Q35183967-233EB4EB-E241-45DA-B5AE-CD533E65E72BQ35215950-E96DD841-78A0-4B8B-B0A5-A0367E018AE8Q35370226-54BA7C86-CB5F-4E43-9935-B055D805C948Q35378689-159381C9-DC01-47CD-8050-E39A9BEAFB44Q35384996-8443AEDA-D374-42C1-B605-96C1113487C2Q35464509-430AE713-94EF-487D-BFC0-0A2C49BD3B9AQ35508990-ABB3D2E3-A07B-4987-927A-AF3FD83EF735Q35533177-FB27BB11-2EA0-46FD-9011-C5AB2285E989Q35551106-787AFA80-287C-4090-9661-30294DCE158BQ35780477-98C074FB-7322-4287-9E4F-E4F11F65BF3BQ35780704-EAD6B8A7-4C80-4558-86C3-2C4416008DD5Q35811091-723617D2-187F-4690-AB5F-1160876EBA35Q35818014-5D3067D1-947C-4865-AAC4-0A4992D82F93Q35822868-5FD8C7BD-22A2-4FC6-9DBA-0CC2CC639E8EQ36519600-109C1EB2-DF80-4A69-B191-5D569DEE52CFQ36521116-C89A96E9-4EC0-4005-BDAA-221FA7B4E420Q36527200-E7673330-E152-4224-9028-2B3FEB205706Q36536825-46F5511F-6125-4EBA-B510-9160CA319864Q36539933-12EC0B97-8CF7-441C-B3A2-418E65DFECB4Q36545835-E3B7997A-BBF0-4CFA-BA47-FB1290D62099Q36652796-B1DAC309-88B0-4045-9347-55852770F11EQ36952865-D80D5957-8638-452A-90AF-4A398F2FF631Q36970751-57B87899-B9C5-41F5-91DB-786ABF2C5D91
P2860
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@en
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@nl
type
label
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@en
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@nl
prefLabel
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@en
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@nl
P2093
P356
P1476
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
@en
P2093
Goldberger MJ
Parenti DM
P304
P356
10.1093/INFDIS/163.6.1326
P407
P577
1991-06-01T00:00:00Z